Basic Care No Drip Nasal Spray Recalled for Contaminated Excipient
Perrigo Company is recalling 1,296 bottles of Basic Care No Drip Nasal Spray (oxymetazoline hydrochloride 0.05%) distributed nationwide due to contaminated excipient used during manufacturing.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall. The source text does not report any illnesses, injuries, or confirmed harm from the contaminated excipient—only that manufacturing did not meet CGMP standards. The recall is a precautionary measure based on the supplier's recall of the excipient itself.
Plain-English summary
Perrigo Company PLC is recalling Basic Care No Drip Nasal Spray (Maximum Strength No Drip Nasal Spray, oxymetazoline hydrochloride 0.05%) because the product was manufactured with contaminated excipient that was itself recalled from the excipient supplier.
The affected product is 1 FL Oz (30 mL) bottles with batch number 1BK0964R and expiration date 01/31/2023, NDC 72288-388-10. A total of 1,296 bottles were distributed nationwide in the USA by Amazon.com Services LLC.
Consumers who have purchased this product should stop using it. Any affected consumers with questions should contact their healthcare provider or pharmacist for guidance.
The recalled product
- Product
- BASIC CARE NO DRIP NASAL (OXYMETAZOLINE HYDROCHLORIDE)
- Brand
- BASIC CARE NO DRIP NASAL
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — OTC Nasal Decongestant
- Affected units
- 1,296
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1BK0964R
- Exp 01/31/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 51 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 51 products in this recall →Related recalls
Same brand · BASIC CARE NO DRIP NASAL
- ModerateOxymetazoline Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateBasic Care No Drip Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same manufacturer · Perrigo Company PLC
See all →- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateUP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same hazard · contaminated excipient
See all →- ModerateEquate Children's Pain and Fever recalled due to contaminated excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Infant Pain and Fever Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
Similar recalls
- ModerateRexall Nasal Spray Recalled for Manufacturing Quality Deviations
FDA (Drugs) · 2018-10-24
- ModerateOTC Nasal Decongestant Recalled Due to Manufacturing Process Deviation
FDA (Drugs) · 2024-01-10
- ModerateNasal Decongestant Recalled for Possible Manufacturing Water Contamination
FDA (Drugs) · 2024-01-10
- ModerateFDA Recalls Premier Value Nasal Spray Due to Manufacturing Deviations
FDA (Drugs) · 2018-10-24
- ModerateOxymetazoline Nasal Spray Recalled Due to Manufacturing Process Deviation
FDA (Drugs) · 2024-01-10
- ModerateWalgreens Severe Anefrin Nasal Spray Recalled for Quality Deviations
FDA (Drugs) · 2018-10-24